BRIDGEWATER, N.J., Feb. 29,
2024 /PRNewswire/ -- Insmed Incorporated
(Nasdaq:INSM), a global biopharmaceutical company on a mission to
transform the lives of patients with serious and rare diseases,
today announced that management will present at the following
investor conferences:
- The TD Cowen 44th Annual Health Care Conference
in Boston on Monday, March 4, 2024, at 2:50 p.m. ET in a fireside chat
- The Leerink Partners Global Biopharma Conference 2024 in
Miami on Tuesday, March 12, 2024, at 1:00 p.m. ET in a fireside chat
- The Barclays 26th Annual Global Healthcare
Conference in Miami on
Wednesday, March 13, 2024, at
4:35 p.m. ET in a fireside chat
Each fireside chat will be webcast live and can be accessed by
visiting the investor relations section of the Company's website
at www.insmed.com. Each webcast will be archived for a
period of 30 days following the conclusion of the live event.
About Insmed
Insmed Incorporated is a global
biopharmaceutical company on a mission to transform the lives of
patients with serious and rare diseases. Insmed's first commercial
product is a first-in-disease therapy approved in the United States, Europe, and Japan to treat a chronic, debilitating lung
disease. The Company is progressing a robust pipeline of
investigational therapies targeting areas of serious unmet need,
including neutrophil-mediated inflammatory diseases and rare
pulmonary disorders. Insmed is also advancing an early-stage
research engine encompassing a wide range of technologies and
modalities, including artificial intelligence-driven protein
engineering, gene therapy, and protein manufacturing. Insmed is
headquartered in Bridgewater, New
Jersey, with additional offices and research locations
throughout the United States,
Europe, and Japan. Visit www.insmed.com to learn more.
Contact:
Investors:
Bryan Dunn
Executive Director, Investor Relations
Insmed
(646) 812-4030
bryan.dunn@insmed.com
Eleanor Barisser
Associate Director, Investor Relations
Insmed
(718) 594-5332
eleanor.barisser@insmed.com
Media:
Mandy Fahey
Executive Director, Corporate Communications
Insmed
(732) 718-3621
amanda.fahey@insmed.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/insmed-to-present-at-three-march-conferences-302075670.html
SOURCE Insmed Incorporated
